| Literature DB >> 25699083 |
Zoltán Násztor1, János Horváth2, Balázs Leitgeb3.
Abstract
In this theoretical study, a conformational analysis was performed on short-sequence hypomurocin A peptides, in order to identify their characteristic structural properties. For each hypomurocin A molecule, not only the backbone conformations, but also the side-chain conformations were examined. The results indicated that certain tetrapeptide units could be characterized by types I and III β-turn structures, and considering the helical conformations, it could be concluded that the hypomurocin A peptides showed a preference for the 310-helical structure over the α-helical structure. Beside the backbone conformations, the side-chain conformations were investigated, and the preferred rotamer states of the side-chains of amino acids were determined. Furthermore, the occurrence of i ← i + 3 and i ← i + 4 intramolecular H-bonds was studied, which could play a role in the structural stabilization of β-turns and helical conformations. On the whole, our theoretical study supplied a comprehensive characterization of the three-dimensional structure of short-sequence hypomurocin A peptides.Entities:
Year: 2015 PMID: 25699083 PMCID: PMC4324929 DOI: 10.1155/2015/281065
Source DB: PubMed Journal: Int J Pept ISSN: 1687-9767
Sequences of the HM A peptides.
| Peptides | Sequences of peptides |
|---|---|
| HM A-1 | Ac–Aib1–Gln2–Val3–Val4–Aib5–Pro6–Leu7–Leu8–Aib9–Pro10–Leuol11 |
| HM A-2 | Ac–D-Iva1–Gln2–Val3–Val4–Aib5–Pro6–Leu7–Leu8–Aib9–Pro10–Leuol11 |
| HM A-3 | Ac–Aib1–Gln2–Val3–Leu4–Aib5–Pro6–Leu7–Ile8–Aib9–Pro10–Leuol11 |
| HM A-4 | Ac–Aib1–Gln2–Ile3–Val4–Aib5–Pro6–Leu7–Leu8–Aib9–Pro10–Leuol11 |
| HM A-5 | Ac–Aib1–Gln2–Ile3–Ile4–Aib5–Pro6–Leu7–Leu8–Aib9–Pro10–Leuol11 |
| HM A-5a | Ac–Aib1–Gln2–Ile3–Leu4–Aib5–Pro6–Leu7–Ile8–Aib9–Pro10–Leuol11 |
Populations (in %) of the types I and III β-turns identified in certain tetrapeptide units of the HM A molecules. Xaa1 = Aib/D-Iva, Xaa3 = Val/Ile, Xaa4 = Val/Leu/Ile, and Xaa8 = Leu/Ile.
| Types I and III | ||||||
|---|---|---|---|---|---|---|
| Tetrapeptide units | HM A-1 | HM A-2 | HM A-3 | HM A-4 | HM A-5 | HM A-5a |
| Xaa1–Gln2–Xaa3–Xaa4 | 9.6 | 8.9 | 8.6 | 8.6 | 8.3 | 11.5 |
| Gln2–Xaa3–Xaa4–Aib5 | 17.1 | 5.2 | 17.7 | 15.7 | 16.2 | 15.1 |
| Xaa4–Aib5–Pro6–Leu7 | 6.1 | 9.6 | 6.3 | 4.4 | 5.7 | 5.8 |
| Aib5–Pro6–Leu7–Xaa8 | 7.1 | 11.3 | 9.6 | 7.2 | 7.9 | 8.7 |
| Pro6–Leu7–Xaa8–Aib9 | 14.5 | 7.4 | 17.1 | 13.4 | 11.6 | 12.4 |
| Xaa8–Aib9–Pro10–Leuol11 | 8.6 | 12.9 | 8.2 | 8.9 | 7.6 | 9.1 |
Figure 1Distributions of the helicity values for the HM A-1 peptide.
Populations (in %) of the conformers characterized by the different helical contents for the HM A peptides.
| Helicity | HM A-1 | HM A-2 | HM A-3 | HM A-4 | HM A-5 | HM A-5a |
|---|---|---|---|---|---|---|
| 310-helical content | ||||||
| 0% | 3.6 | 3.7 | 3.8 | 3.1 | 4.1 | 2.5 |
| 10% | 14.4 | 15.2 | 15.2 | 14.9 | 15.5 | 14.8 |
| 20% | 25.8 | 23.2 | 26.3 | 28.2 | 24.9 | 24.5 |
| 30% | 26.2 | 24.0 | 25.4 | 24.6 | 28.3 | 26.0 |
| 40% | 18.7 | 18.8 | 17.5 | 17.8 | 16.2 | 19.0 |
| 50% | 7.6 | 10.2 | 7.4 | 8.7 | 7.7 | 9.6 |
| 60% | 2.3 | 3.7 | 3.5 | 2.4 | 2.6 | 2.7 |
| 70% | 1.2 | 1.1 | 0.7 | 0.2 | 0.6 | 0.9 |
| 80% | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 |
|
| ||||||
|
| ||||||
| 0% | 22.5 | 14.9 | 23.8 | 23.0 | 21.0 | 19.2 |
| 10% | 39.4 | 33.6 | 35.6 | 37.5 | 39.7 | 37.5 |
| 20% | 24.5 | 27.7 | 29.1 | 27.3 | 27.3 | 27.4 |
| 30% | 10.1 | 17.2 | 9.5 | 9.7 | 8.8 | 12.3 |
| 40% | 3.1 | 4.6 | 1.4 | 2.1 | 2.8 | 2.7 |
| 50% | 0.3 | 1.7 | 0.5 | 0.3 | 0.4 | 0.8 |
| 60% | 0.1 | 0.3 | 0.1 | 0.1 | 0.0 | 0.1 |
Proportions (in %) of the g(+), g(−), and trans rotamers for the side-chains of the amino acids of HM A peptides. Xaa3 = Val/Ile, Xaa4 = Val/Leu/Ile, and Xaa8 = Leu/Ile.
| Rotamers | D-Iva1 | Gln2 | Xaa3 | Xaa4 | Leu7 | Xaa8 | Leuol11 |
|---|---|---|---|---|---|---|---|
| HM A-1 | |||||||
| g(+) | — | 22.0 | 22.0 | 20.1 | 14.4 | 14.5 | 16.3 |
| g(−) | — | 54.5 | 50.3 | 51.3 | 48.5 | 47.5 | 51.1 |
|
| — | 23.5 | 27.7 | 28.6 | 37.1 | 38.0 | 32.6 |
|
| |||||||
| HM A-2 | |||||||
| g(+) | 45.7 | 19.7 | 22.2 | 20.9 | 15.1 | 14.7 | 13.1 |
| g(−) | 30.0 | 52.2 | 51.5 | 52.6 | 46.5 | 48.0 | 57.5 |
|
| 24.3 | 28.1 | 26.3 | 26.5 | 38.4 | 37.3 | 29.4 |
|
| |||||||
| HM A-3 | |||||||
| g(+) | — | 18.8 | 21.7 | 13.3 | 14.7 | 42.2 | 15.9 |
| g(−) | — | 57.8 | 48.9 | 46.6 | 46.1 | 23.6 | 50.5 |
|
| — | 23.4 | 29.4 | 40.1 | 39.2 | 34.2 | 33.6 |
|
| |||||||
| HM A-4 | |||||||
| g(+) | — | 20.1 | 49.0 | 24.4 | 17.0 | 15.5 | 14.4 |
| g(−) | — | 52.7 | 21.4 | 46.5 | 44.5 | 45.2 | 53.6 |
|
| — | 27.2 | 29.6 | 29.1 | 38.5 | 39.3 | 32.0 |
|
| |||||||
| HM A-5 | |||||||
| g(+) | — | 18.6 | 47.6 | 41.5 | 17.3 | 15.5 | 14.8 |
| g(−) | — | 55.3 | 22.4 | 24.0 | 46.3 | 45.4 | 50.3 |
|
| — | 26.1 | 30.0 | 34.5 | 36.4 | 39.1 | 34.9 |
|
| |||||||
| HM A-5a | |||||||
| g(+) | — | 21.9 | 40.5 | 15.6 | 15.9 | 43.4 | 13.8 |
| g(−) | — | 52.7 | 23.7 | 43.4 | 43.5 | 19.5 | 53.5 |
|
| — | 25.4 | 35.8 | 41.0 | 40.6 | 37.1 | 32.7 |
Populations (in %) of the different types of i ← i + 3 and i ← i + 4 H-bonds for the HM A peptides. Xaa1 = Aib/D-Iva, Xaa4 = Val/Leu/Ile, and Xaa8 = Leu/Ile.
| Intramolecular H-bonds | ||||||
|---|---|---|---|---|---|---|
|
| HM A-1 | HM A-2 | HM A-3 | HM A-4 | HM A-5 | HM A-5a |
|
| ||||||
| Xaa1← Xaa4 | 11.4 | 13.1 | 14.0 | 12.7 | 10.8 | 13.3 |
| Gln2← Aib5 | 10.0 | 8.8 | 12.9 | 10.0 | 9.3 | 10.1 |
| Xaa4← Leu7 | 8.0 | 12.3 | 9.3 | 6.2 | 7.9 | 7.2 |
| Aib5← Xaa8 | 12.2 | 16.2 | 11.2 | 13.2 | 11.5 | 9.2 |
| Pro6← Aib9 | 11.9 | 11.2 | 11.2 | 10.0 | 11.1 | 10.4 |
| Xaa8← Leuol11 | 8.7 | 16.7 | 7.7 | 7.3 | 7.5 | 8.7 |
|
| ||||||
|
| HM A-1 | HM A-2 | HM A-3 | HM A-4 | HM A-5 | HM A-5a |
|
| ||||||
| Xaa1← Aib5 | 2.9 | 3.2 | 2.3 | 2.5 | 1.5 | 2.9 |
| Xaa3← Leu7 | 1.1 | 0.1 | 1.1 | 1.5 | 0.7 | 1.6 |
| Xaa4← Xaa8 | 1.2 | 2.7 | 1.2 | 1.3 | 1.9 | 1.2 |
| Aib5← Aib9 | 2.5 | 5.6 | 3.1 | 2.8 | 3.2 | 1.5 |
| Leu7← Leuol11 | 0.9 | 0.6 | 1.4 | 1.3 | 1.0 | 1.9 |